The role of glimepiride in the effective management of Type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of diabetes and its complications

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JDIACOMP.2004.07.001PMID 15531188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Practice Recommendations 2005.

  2005cited by this paper
• Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.

  2003cited by this paper
• Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.

  2003cited by this paper
• Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen.

  2003cited by this paper
• Evaluation of innovative skin-marking technique performed before thyroid ultrasound-guided fine-needle aspiration biopsies.

  2002cited by this paper
• Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 Diabetes

  2002cited by this paper
• Combination therapy of alpha-glucosidase inhibitor and a sulfonylurea compound prolongs the duration of good glycemic control.

  2002cited by this paper
• Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.

  2002cited by this paper
• Improved Metabolic Control with a Favorable Weight Profile in Patients with Type 2 Diabetes Treated with Insulin Glargine in Clinical Practice

  2002cited by this paper
• Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

  2002cited by this paper
• Management of Type 2 Diabetes Mellitus in the Elderly

  2001influential reference
• Glimepiride, a Novel Sulfonylurea, Does Not Abolish Myocardial Protection Afforded by Either Ischemic Preconditioning or Diazoxide

  2001cited by this paper
• Efficacy and Tolerability of Glimepiride in Daily Practice

  2001cited by this paper
• Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

  2001cited by this paper
• Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients

  2001cited by this paper
• Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.

  2000cited by this paper
• The effect of glimepiride on some haemostatic parameters in patients with type 2 diabetes mellitus

  2000cited by this paper
• Long-term treatment of type 2 diabetes mellitus with glimepiride is weight neutral: A meta-analysis

  2000cited by this paper
• Clinical prospective Latinoamerican experience with glimepiride in the treatment of diabetes mellitus type 2

  2000cited by this paper
• Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.

  1999cited by this paper
• Ischemic preconditioning, myocardial stunning, and hibernation: basic aspects.

  1999cited by this paper
• A Placebo‐Controlled, Randomized Study of Glimepiride in Patients with Type 2 Diabetes Mellitus for Whom Diet Therapy is Unsuccessful

  1998cited by this paper
• Glimepiride

  1998cited by this paper
• Type 2 diabetes: update on therapy.

  1998cited by this paper
• Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin Alone

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Current therapy of diabetes mellitus

  1998cited by this paper
• The sulfonylurea controversy: more questions from the heart.

  1998cited by this paper
• The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.

  1997cited by this paper
• Tactics for type II diabetes.

  1997cited by this paper
• Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.

  1997cited by this paper
• Short-Term Comparison of Once- versus Twice-Daily Administration of Glimepiride in Patients with Non-Insulin-Dependent Diabetes Mellitus

  1997cited by this paper
• Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials

  1997cited by this paper
• Glimepiride, a New Once-Daily Sulfonylurea: A double-blind placebo-controlled study of NIDDM patients

  1996cited by this paper
• Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

  1996cited by this paper
• Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

  1996cited by this paper
• Cardiovascular Effects of Conventional Sulfonylureas and Glimepiride

  1996cited by this paper
• Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.

  1996cited by this paper
• A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

  1996cited by this paper
• Combined Therapy With a Sulfonylurea Plus Evening Insulin: Safe, Reliable, and Becoming Routine

  1996cited by this paper
• Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients.

  1996cited by this paper
• Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations

  1996cited by this paper
• The Effects of Acute Exercise on Metabolic Control in Type II Diabetic Patients Treated with Glimepiride or Glibenclamide

  1996cited by this paper
• A Dose-Response Study of Glimepiride in Patients With NIDDM Who Have Previously Received Sulfonylurea Agents

  1996cited by this paper
• Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

  1996cited by this paper
• Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.

  1996cited by this paper
• Long-Term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl®): A Double-Blind Comparison with Glibenclamide

  1996cited by this paper
• United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications in Non-Insulin-dependent Diabetes Mellitus

  1996cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.

  1995cited by this paper
• The molecular interaction of sulfonylureas with β-cell ATP-sensitive K+-channels

  1995cited by this paper
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

  1995cited by this paper
• Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM

  1994cited by this paper
• Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.

  1994influential reference
• Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM

  1994cited by this paper
• Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp.

  1992cited by this paper
• Standards of Medical Care for Patients With Diabetes Mellitus

  1991cited by this paper
• Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.

  1991cited by this paper
• Characterization and Significance of Sulfonylurea Receptors

  1990cited by this paper
• Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

  1989cited by this paper
• Drugs and Aging

  1987cited by this paper
• Efficacy of Glyburide in Diabetics Poorly Controlled on First-Generation Oral Hypoglycemics

  1987cited by this paper
• Insulin secretion in diabetes mellitus.

  1981cited by this paper

• From inflammation to intervention: exploring shared mechanisms and lifestyle strategies in diabetes mellitus and multiple sclerosis.

  2025cites this paper
• Effects of Cirsium japonicum var. maackii on avelliation of metabolic disease by improving insulin resistance

  2025cites this paper
• The Clinical Pharmacokinetics and Pharmacodynamics of Glimepiride—A Systematic Review and Meta-Analysis

  2025cites this paper
• Solubility, thermodynamic properties and predictive modeling of glimepiride in various solvents

  2025cites this paper
• Nano-Based Drug Delivery Systems for Managing Diabetes: Recent Advances and Future Prospects

  2025cites this paper
• Pd-Catalyzed Enantioselective Three-Component Carboamination of 1,3-Cyclohexadiene.

  2024cites this paper
• Study of Plasma Adiponectin Levels in Patients with Metabolic Syndrome and Therapeutic Indication in Bangladesh

  2024cites this paper
• Eco-friendly HPLC method by using response surface design to measure a combination of three antidiabetic drugs

  2023cites this paper
• Comparative Efficacy of Combined Formulation of Andrographis paniculata, Lagerstroemia speciosa and Tribulus terrestris with Glimepiride on Renal and Pancreatic Injury in Alloxan Induced Type-1 Diabetic Mice

  2023cites this paper
• Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial

  2023cites this paper
• Carboxylated gums as additives in the production of interpenetrating hydrogel beads and slow release of glimepiride

  2022cites this paper
• Effect Of SMEEDS Formulation Of Glimepiride In Combination With Boswellic Acid Extract In Diabetic Induced Rats To Mimic Diabetic Complications

  2022cites this paper
• Formulation Characterization Optimization of Duloxetine loaded Ethosome Patch for Transdermal Application

  2022cites this paper
• Ascendancy of pH ‐irresponsive Moi gum in the design of modified xanthan gum semi‐interpenetrating network hydrogels for monitoring diabetes

  2022cites this paper
• Formulation and evaluation of buccal bioadhesive tablets using glimepiride as a model drug

  2021cites this paper
• Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2

  2021cites this paper
• Heteroleptic cadmium complex of glimepiride–metformin mixed ligand: synthesis, characterization, and antibacterial study

  2021cites this paper
• Formulation and Evaluation of Glimepiride Loaded Cellulose Acetate Microparticles Prepared by An Emulsion Solvent Evaporation Method

  2020cites this paper
• Physicochemical Characterization, Molecular Docking, and In Vitro Dissolution of Glimepiride–Captisol Inclusion Complexes

  2020cites this paper
• Improved Transmucosal Delivery of Glimepiride via Unidirectional Release Buccal Film Loaded With Vitamin E TPGS-Based Nanocarrier

  2020cites this paper
• Asymmetric Three-Component Heck/Amination of Nonconjugated Cyclodienes.

  2020cites this paper
• In-vitro and in-vivo performance of locally manufactured glimepiride tablet generics compared to the innovator (Amaryl®) tablets

  2020cites this paper
• Asymmetric Three‐Component Heck Arylation/Amination of Nonconjugated Cyclodienes

  2020cites this paper
• Effect of Sulphonylurea Derivatives and Short Chain Fatty Acids on Expression of Incretins Hormone in living Animal Cells

  2020cites this paper
• 5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.

  2020cites this paper
• GAMBARAN PENGGUNAAN OBAT DIABETES MELLITUS PADA PASIEN DIABETES MELLITUS TIPE 2

  2020cites this paper
• Development and Validation of New Analytical Method for the Determination of Particle Size Distribution in Glimepiride Using Laser Based Particle Size Analyzer

  2019cites this paper
• In-vitro Fluorescence Spectroscopic Analysis of the Interaction of Glimepiride with Bovine Serum Albumin (BSA)

  2019cites this paper
• Electrochemical Behavior of Valsartan, Glibenclamide and their Interaction with Each other Using Square Wave Voltammetry

  2019cites this paper
• MANAGING DIABETES MELLITUS: A WAY FORWARD

  2019influential citation
• Comparative effect of saxagliptin and glimepiride with a composite endpoint of adequate glycaemic control without hypoglycaemia and without weight gain in patients uncontrolled with metformin therapy: Results from the SPECIFY study, a 48‐week, multi‐centre, randomized, controlled trial

  2019cites this paper
• Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture

  2019cites this paper
• Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic Drugs.

  2019cites this paper
• Discovery of potent and orally bioavailable indazole-based glucagon receptor antagonists for the treatment of type 2 diabetes.

  2019cites this paper
• Type II diabetes mellitus and obesity: Common links, existing therapeutics and future developments

  2019cites this paper
• Glycemic Excursions in Diabetic Kidney Disease: Comparison of Three Therapeutic Arms

  2018cites this paper
• Solubility enhancement of glimperide: Development of solid dispersion by solvent melt method, characterization and dosage form development

  2018cites this paper
• Design, synthesis and biological evaluation of (2S,3R,4R,5S,6R)-5-fluoro-6-(hydroxymethyl)-2-aryltetrahydro-2H-pyran-3,4-diols as potent and orally active SGLT dual inhibitors.

  2018cites this paper
• Antidiabetic effect of extra virgin olive oil from the ‘Rougette’ variety of the Skikda region of eastern Algeria

  2018cites this paper
• Metabolic impairments and tissue disorders in alloxan-induced diabetic rats are alleviated by Salvia officinalis L. essential oil.

  2018cites this paper
• Formulation and evaluation of microencapsulated Glimepiride produced by the emulsion - solvent evaporation method

  2018cites this paper
• FT-IR, Raman, and NMR Spectroscopy and DFT Theory of Glimepiride Molecule as a Sulfonylurea Compound

  2018cites this paper
• FORMULATION CHARACTERIZATION AND EVALUATION OF TRANSDERMAL PATCHES OF GLIMEPIRIDE

  2017cites this paper
• An Efficient and Practical Process for the Synthesis of Glimepiride

  2017cites this paper
• A rapid hydrophilic interaction liquid chromatographic determination of glimepiride in pharmaceutical formulations

  2017cites this paper
• Formulation and Evaluation of New Glimepiride Sublingual Tablets

  2017cites this paper
• Development of Solid-Phase Extraction and HPLC Method for Simultaneous Estimation of Ilaprazole and Glimepiride in Rat Plasma: Application to Pharmacokinetic Studies.

  2017cites this paper
• Efficacy and safety of sitagliptin/metformin fixed‐dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double‐blind study

  2017cites this paper
• Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9

  2017cites this paper
• The Effect of Some Fruit Juices on Glimepiride Pharmacokinetic in Rat Plasma by Using High Performance Liquid Chromatography-Mass Spectrometry

  2017cites this paper
• A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

  2017cites this paper
• The Role of TRP Channels in the Pancreatic Beta-Cell

  2017cites this paper
• Preparation and Characterization of Biodegradable Glimepiride Loaded PLA Nanoparticles by o / w Solvent Evaporation Method Using High Pressure Homogenizer : A Factorial Design Approach

  2016cites this paper
• Modulatory Role of Selenium Nanoparticles and Grape Seed Extract Mixture on Oxidative Stress Biomarkers in Diabetic Irradiated Rats

  2016cites this paper
• Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.

  2016cites this paper
• ROLE OF RASAGILINE, A MAO-B INHIBITOR IN STREPTOZOTOCIN INDUCED DIABETIC NEPHROPATHY.

  2016cites this paper
• Enhancing Transdermal Delivery of Glimepiride Via Entrapment in Proniosomal Gel

  2016cites this paper
• Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

  2015influential citation
• The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism.

  2015cites this paper
• Analysis of Glimepiride in Human Blood and Urine by Thin Layer Chromatography and UV Spectrophotometry

  2015cites this paper
• Oral antihyperglycemic treatment options for type 2 diabetes mellitus.

  2015cites this paper
• The role of glimepiride in combination with metformin in modern practice of using antihyperglycemic therapy for type 2 diabetes mellitus

  2015cites this paper
• Amaryl®М SR: a New Release Form, New Possibilities for The Patients

  2015cites this paper
• Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysis

  2015cites this paper
• DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC METHOD FOR ESTIMATION OF GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE

  2015cites this paper
• COMPLEXATION STUDY OF GLIMEPIRIDE WITH Mg

  2015cites this paper
• Formulation and Evaluation of Glimepiride Oral Capsules

  2015influential citation
• METHANOL BY CONDUCTOMETRY, SPECTROPHOTOMETRY AND LC-MS

  2015cites this paper
• Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes

  2014cites this paper
• Effect of glimepiride on the skeletal system of ovariectomized and non-ovariectomized rats

  2014cites this paper
• The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study

  2014cites this paper
• Development and validation of RP-HPLC method for glimepiride and its application for a novel self-nanoemulsifying powder (SNEP) formulation analysis and dissolution study

  2014cites this paper
• FORMULATION AND EVALUATION OF GLIMEPIRIDE LOADED CELLULOSE ACETATE MICROPARTICLES

  2014cites this paper
• Modifications of physical properties of selected Oral antidiabetics to enhance solubility Dissolution and therapeutic efficacy

  2014cites this paper
• Preparation and Characterization of Biodegradable Glimepiride Loaded PLA Nanoparticles by o/w Solvent Evaporation Method Using High Pressure Homogenizer: A Factorial Design Approach

  2014cites this paper
• Smallanthus macroscyphus: a new source of antidiabetic compounds.

  2014cites this paper
• Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes.

  2014cites this paper
• COMPARATIVE IN VITRO DRUG RELEASE STUDIES OF GLIMEPIRIDE SOLID DISPERSIONS & METFORMIN MICROCAPSULES

  2014cites this paper
• Formulation and Evaluation of Glimepiride Microparticles

  2014cites this paper
• Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus

  2013cites this paper
• Glycemic variability: Clinical implications

  2013cites this paper
• Spectrophotometric determination of glimepiride in pharmaceutical preparations based on the formation of charge-transfer and ion-pair complexes

  2013cites this paper
• Hypoglycaemia due to interaction of glimepiride with isoniazid in a patient with type 2 diabetes mellitus

  2013cites this paper
• Study Effect of Glimepiride and Repaglinide on CIMT and Long Glycemic Control in Type 2 Diabetic Patients Double Blind Study

  2013cites this paper
• Original article Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus

  2013cites this paper
• Глимепирид в современной гипогликемизирующей терапии: безопасность и эффективность

  2012cites this paper
• Discovery of Heterocyclic Phosphonic Acids as Novelampmimics that are Potent and Selective Fructose‐1,6‐Bisphosphatase Inhibitors and Elicit Potent Glucose‐Lowering Effects in Diabetic Animals and Humans

  2012cites this paper
• ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2012cites this paper
• Modern antihyperglycemic therapy: safety and efficacy of glimepiride

  2012cites this paper
• Simultaneous Determination of Atorvastatin and Glimepiride by LC-MS/MS in Human Plasma and Its Application to a Pharmacokinetic Study

  2012cites this paper
• Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.

  2012cites this paper
• Investigation of an active film coating to prepare new fixed-dose combination tablets for treatment of diabetes.

  2012cites this paper
• Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies.

  2012cites this paper
• SOLUBILITY AND DISSOLUTION ENHANCEMENT OF POORLY WATER SOLUBLE GLIMEPIRIDE BY USING SOLID DISPERSION TECHNIQUE

  2012cites this paper
• Design, Development and Evaluation of Metformin Hydrochloride and Glimepiride Immediate Release Tablets

  2012cites this paper
• FORMULATION AND EVALUATION OF GLIMEPIRIDE SOLID DISPERSIONS AND THEIR TABLET FORMULATIONS FOR ENHANCED BIOAVAILABILITY

  2011cites this paper
• Effect of Metformin and Glimepiride on Liver and Kidney Functions in Alloxan-Induced Diabetic Rats

  2011cites this paper
• POLIVINYL PYRROLIDINE-AN APPROACH TO ENHANCE THE SOLUBILITY AND DISSOLUTION OF VALDECOXIB TABLETS

  2011cites this paper
• Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover

  2011cites this paper
• Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study

  2011cites this paper